Screener
Corcept Therapeutics CORT Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Corcept Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: Corcept Therapeutics’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:09 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-050613
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Trade receivables, net of allowances | 76,920 | 59,786 |
| Inventory | 13,185 | 12,868 |
| Prepaid expenses and other current assets | 41,374 | 40,658 |
| Total current assets | 439,676 | 485,464 |
| Strategic inventory | 18,956 | 11,094 |
| Operating lease right-of-use asset | 6,860 | 4,583 |
| Property and equipment, net | 5,133 | 1,890 |
| Long-term marketable securities | 236,451 | 160,270 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Corcept Therapeutics's total current assets?
- Corcept Therapeutics (CORT) reported total current assets of $439.68M in Q2 2026.
- How has Corcept Therapeutics's total current assets changed year-over-year?
- Corcept Therapeutics's total current assets decreased by 0.8% year-over-year, from $443.11M to $439.68M.
- What is the long-term trend for Corcept Therapeutics's total current assets?
- Over 5 years (2020 to 2025), Corcept Therapeutics's total current assets has grown at a 0.3% compound annual growth rate (CAGR), from $478.5M to $485.46M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about Corcept Therapeutics's total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude